Alba Sebastián Martín-rekin lankidetzan egindako argitalpenak (4)

2024

  1. Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM)

    Life Sciences, Vol. 336

2023

  1. Resistance to 2-Hydroxy-Flutamide in Prostate Cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

2022

  1. A Highly Sensitive Immunoassay for Determination of Immune Response to SARS-CoV-2 in Capillary Blood Samples

    Biomedicines, Vol. 10, Núm. 11

  2. Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology

    Biomedicines, Vol. 10, Núm. 8